The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions. [electronic resource]
Producer: 20021104Description: 416-21 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Belgium
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Feasibility Studies
- Female
- Fluorouracil -- therapeutic use
- Humans
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Methotrexate -- therapeutic use
- Middle Aged
- Postmenopause
- Premenopause
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.